Brazilian Journal of Implantology and Health Sciences,
Год журнала:
2024,
Номер
6(1), С. 212 - 227
Опубликована: Янв. 5, 2024
Esta
revisão
sistemática
tem
por
objetivo
comparar
os
medicamentos
utilizados
para
tratamento
da
covid19
em
pacientes
diagnosticados
com
a
doença
e
internados.
A
busca
nas
bases
dados
gerou
97
referências,
que
após
o
processo
de
seleção
elegibilidade,
foram
selecionadas
4
revisões
sistemáticas
(RS)
utilizadas
nesta
síntese
narrativa
onde
seus
extraídos.
ferramenta
AMSTAR
2
foi
utilizada
na
avaliação
qualidade
metodológica.
As
opções
agrupadas
acordo
as
intervenções
adotadas:
Tociluzumabe,
vitamina
D
Atorvastatina.
Conclui-se
estudo
possui
limitações
sua
metodologia,
devendo
resultados
serem
analisados
prudência.
apresentadas
necessitam
descrever
padrão
utilizado.
O
tociluzumabe
se
mostra
melhor
escolha
uso
concomitante
padrão.
BMC Infectious Diseases,
Год журнала:
2022,
Номер
22(1)
Опубликована: Май 7, 2022
Serum
vitamin
D
levels
may
have
a
protective
role
against
severe
coronavirus
disease
2019
(COVID-19).
Studies
shown
that
deficiency
in
be
significant
risk
factor
for
poor
outcomes.
This
study
aims
to
compare
the
outcome
and
clinical
condition
of
patients
diagnosed
with
COVID-19
infection
considering
serum
levels.In
this
cross-sectional
study,
202
without
known
cardiovascular
(reduced
ejection
fraction,
uncontrolled
arrhythmia,
pericardial
effusion,
cardiac
block,
valvular
disease,
or
hypertension)
were
included.
Patients
divided
into
three
groups
insufficient
(<
30
ng/mL),
normal
(30
50
high
(>
ng/mL)
levels.
Clinical
was
defined
as
if
invasive
respiratory
intervention
ICU
admission
required.The
based
on
their
level:
127
cases
group,
53
22
group.
The
mean
age
population
56
years.
Thirty-four
had
distribution
group
follows:
21
(16.5%),
eight
(15.1%),
five
(22.7%);
P
=
0.74.
No
differences
found
between
terms
mortality
rate
(P
0.46).
Moreover,
leukocytes
(mean
±
SD
6873.5
4236.2),
ESR
38.42
26.7),
CPK-MB
63
140.7)
higher
but
it
not
statistically
>
0.05).The
finding
present
showed
could
make
difference
systems,
laboratory
results,
severity
patients.
PubMed,
Год журнала:
2021,
Номер
92(S6), С. e2021451 - e2021451
Опубликована: Окт. 1, 2021
Vitamin
D
is
known
to
modulate
immune
response
and
its
deficiency
was
associated
with
respiratory
distress
in
patients
hospitalized
for
pneumonia.
Nevertheless,
numerous
reviews
on
vitamin
COVID-19
have
shown
conflicting
results,
as
previously
reported
also
other
diseases
(e.g.,
influenza).This
umbrella
review
aims
assess
whether
low
serum
25-OHD
susceptibility
COVID
19,
their
severity,
mortality.
A
total
of
1559
studies
were
excluded
after
the
title,
abstract
full-text
articles
screening
9
papers
included
this
review:
2
systematic
7
metanalysis.The
findings
that
summarized
from
5
WHO
regions
(European
Region,
Region
Americas,
South-East
Asia
Eastern
Mediterranean
Western
Pacific
Region)
exclusion
only
African
region,
show
levels
are
higher
infection
risks
COVID-19.Although
indicate
a
potential
role
severity
showing
an
association
between
supplementation
however,
more
robust
data
randomized
controlled
trials
further
needed
confirm
possible
mortality
rates.
Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences,
Год журнала:
2023,
Номер
77(3-4), С. 153 - 161
Опубликована: Авг. 1, 2023
Abstract
Vitamin
D
insufficiency
is
associated
with
poor
prognosis
in
COVID-19
patients.
supplementation
related
to
improved
clinical
outcomes
terms
of
intensive
care
unit
admission
and
death,
particularly
individuals
moderate-to-severe
forms
COVID-19.
The
placebo-controlled
five-day
study
was
performed
on
99
hospitalised
patients
vitamin
randomised
into
two
groups.
the
form
a
sublingual
sprayable
microemulsion
given
three
times
daily
(daily
dose
12,000
IU)
51
blood
25(OH)D
levels
below
30
ng/ml.
Forty-eight
control
group
received
placebo
spray
same
regimen.
Intention-to-treat
(ITT)
analysis
pre-protocol
were
used
verify
impact
level
elevation
inflammatory
markers.
There
statistically
significant
increase
by
8.7
±
7.6
ng/ml
from
baseline
15.6
6.5
case
group.
Individuals
moderately
severe
disease
showed
negative
correlation
between
changes
C-reactive
protein
(CRP)
both
ITT
(
p
<
0.05).
Mild
cases
no
statistical
significance
CRP
levels.
ferritin
IL-6
analysis.
In
conclusion,
high-dose
therapy
accompanied
decrease
moderate
illness.
CAND Journal,
Год журнала:
2023,
Номер
30(4), С. 15 - 31
Опубликована: Дек. 28, 2023
Objective:
This
umbrella
review
synthesizes
the
existing
literature
on
role
of
vitamins
for
COVID-19
prevention
and
management.
The
objective
is
to
elucidate
potential
preventive
therapeutic
dimensions
these
vitamins,
highlight
clinical
applicability,
identify
avenues
future
research.
Methods:
A
systematic
search
was
conducted
using
PubMed
Google
Scholar,
with
predefined
key
words
each
vitamin
combined
COVID-19-related
terms.
Narrative
reviews
were
included,
following
Cochrane
guidelines.
AMSTAR
scoring
used
assess
quality,
while
SANRA
guidelines
evaluate
narrative
reviews.
Data
extraction,
synthesis,
reference
overlap
conducted.
Findings:
(n=14)
revealed
preclinical
benefits
A,
B
group,
C,
D,
E
(no
research
K
found)
in
management,
immune
modulation
anti-inflammatory
responses.
Of
(n=44),
none
included
or
E.
Some
exhibited
potential,
significant
associations
between
C
supplementation
reduced
severity.
Many
findings
also
found
D
deficiency
heightened
risks,
as
well
promising
effects
supplementation.
Conclusion:
Vitamins
hold
mechanistic
rationale
combating
COVID-19,
suggested
by
In
reviews,
underscores
its
severity,
show
adjunct
therapies.
highlights
comprehensive
efficacy
addressing
challenges
that
warrant
further
investigation.
Brazilian Journal of Implantology and Health Sciences,
Год журнала:
2024,
Номер
6(1), С. 212 - 227
Опубликована: Янв. 5, 2024
Esta
revisão
sistemática
tem
por
objetivo
comparar
os
medicamentos
utilizados
para
tratamento
da
covid19
em
pacientes
diagnosticados
com
a
doença
e
internados.
A
busca
nas
bases
dados
gerou
97
referências,
que
após
o
processo
de
seleção
elegibilidade,
foram
selecionadas
4
revisões
sistemáticas
(RS)
utilizadas
nesta
síntese
narrativa
onde
seus
extraídos.
ferramenta
AMSTAR
2
foi
utilizada
na
avaliação
qualidade
metodológica.
As
opções
agrupadas
acordo
as
intervenções
adotadas:
Tociluzumabe,
vitamina
D
Atorvastatina.
Conclui-se
estudo
possui
limitações
sua
metodologia,
devendo
resultados
serem
analisados
prudência.
apresentadas
necessitam
descrever
padrão
utilizado.
O
tociluzumabe
se
mostra
melhor
escolha
uso
concomitante
padrão.